SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-027158
Filing Date
2011-05-09
Accepted
2011-05-09 10:51:48
Documents
11
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a11-9466_110q.htm 10-Q 1224404
2 EX-31.1 a11-9466_1ex31d1.htm EX-31.1 11961
3 EX-31.2 a11-9466_1ex31d2.htm EX-31.2 11961
4 EX-32.1 a11-9466_1ex32d1.htm EX-32.1 6121
5 EX-32.2 a11-9466_1ex32d2.htm EX-32.2 6196
  Complete submission text file 0001104659-11-027158.txt   4342783

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT amag-20110331.xml EX-101.INS 592869
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amag-20110331.xsd EX-101.SCH 24664
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amag-20110331_cal.xml EX-101.CAL 48198
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT amag-20110331_lab.xml EX-101.LAB 295833
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amag-20110331_pre.xml EX-101.PRE 140141
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amag-20110331_def.xml EX-101.DEF 94569
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02421 6174983300
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10865 | Film No.: 11821837
SIC: 2834 Pharmaceutical Preparations